Search Results 831-840 of 17881 for Assay

1. A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis - Mayo Clinic

   Documented positive AMA titer (> 1:40 titer on immunofluorescence or M2 positive by enzyme-linked immunosorbent assay) or PBC-specific ANA immuno ...

2. Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease - Mayo Clinic

   Impaired liver function defined as liver function tests assay>3x the upper limit of normal (ULN) and/or coagulopathy. Impaired renal function, with ...

3. Infectious Diseases! Clinical Trials - Mayo Clinic Research

   This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

4. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Serum Free light chain (FLC) assay: Involved FLC level >=10 mg/dL (>=100 mg/L) and an abnormal serum free light chain ratio (<0.26 or >1.65). Subjects with ...

5. A Study Using VE303 to Prevent Recurrence of Clostridium Difficile Infection - Mayo Clinic

   difficile stool assay by EIA for Toxin A and/or B performed at the local laboratory or a study specific assay performed at the central laboratory. Women of ...

6. Publications - Aziza Nassar, M.D., M.P.H. - Mayo Clinic

   Concordance of Oncotype DX Breast Recurrence Score Assay Results Between Paired Core Needle Biopsy and Surgical Excision Specimens in Hormone Receptor ...

7. NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS - Mayo Clinic

   ... assay and discussed with the Sponsor prior to study entry;. - For cohorts 2U, 7U, and 8U: Additional subjects who have relapsed following HCT may be enrolled ...

8. A Study to Characterize Functional Biomarkers of Systemic Lupus Erythematosus (SLE) - Mayo Clinic

   Subjects diagnosed with the Human Immunodeficiency Virus (HIV), or who have tested positive for HIV, documented by any licensed ELISA assay and confirmed by ...

9. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay.

10. Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML - Mayo Clinic

    * Participants with newly diagnosed AML with FLT3-ITD mutations (FLT3-ITD \[+\]) present at ≥5% VAF (or ≥0.05 SR) based on a validated FLT3 mutation assay.